The Unlicensed Lives of Antidepressants in India: Generic Drugs,Unqualified Practitioners,and Floating Prescriptions

Abstract

Antidepressant uses have been rising rapidly over the past decades. Two main theories have been advanced to explain this. One claims that socio-economic change causes a global rise of depressive illness. The other holds that European and North American corporations are aggressively marketing antidepressants to expand their global reach. Both theories assume that multinational capitalism drives rising depression rates. Based on ethnographic data from India, this article shows that antidepressants are increasingly used in this country as well, but for reasons than have been little explored yet. Taking fluoxetine (Prozac) as the main example, it is argued that the spread of antidepressants in India is `unlicensed' by Euro-American corporations in at least three ways: (i) drug marketing is driven by Indian generic producers; (ii) fluoxetine is given by practitioners who have no license to do so; and (iii) knowledge of fluoxetine is spread through unlicensed `floating' prescriptions that patients take from one prescriber to another.

Keywords

depression globalization India fluoxetine prescription practices psychopharmaceuticals

Get full access to this article

View all access options for this article.

References

Applbaum, K. (2006). Educating for global mental health. In A. Petryna , A. Lakoff , & A. Kleinman (Eds.), Global pharmaceuticals (pp. 85-110). Durham, NC: Duke University Press.

Bhugra, D. , & Mastrogianni, A. (2004). Globalisation and mental disorders: Overview with relation to depression. British Journal of Psychiatry, 184, 10-20.

Braithwaite, J. , & Drahos, P. (2000). Global business regulation. Cambridge: Cambridge University Press.

Chaudhuri, S. (2005). The WTO and India's pharmaceuticals industry. New Delhi, India: Oxford University Press.

Clarke, A.E. , Shim, J.K. , Mamo, L. Fosket, J.R. , & Fishman, J.R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. medicine. American Sociological Review, 68(2), 161-194.

Dr. Reddy's Limited. (2006). Annual report 2005-2006: Creating global enterprise. Retrieved, July 31, 2007, from http://www.drreddys.com/investors/annualreports.htm.

Ecks, S. (2008). Global pharmaceutical markets and corporate citizenship: The case of Novartis' anti-cancer drug Glivec. BioSocieties , 3, 165-181.

Eli Lilly. (2007). Welcome to Prozac.com. Retrieved, July 31, 2007, from http://www.prozac.com/index.jsp .

Ernst & Young. (2005). Unveiling India's pharmaceutical future: Health sciences industry report. Retrieved, July 31, 2007, from http://www.ey.com/global/download.nsf/India/HS_INDIA/$file/INDIA.pdf.

10.

Government of India. (2003). Report of the expert committee on a comprehensive examination of drug regulatory issues, including the problem of spurious drugs. New Delhi : Ministry of Health and Family Welfare.

11.

Healy, D. (1998). The antidepressant era. Cambridge, MA: Harvard University Press.

12.

Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press.

13.

Jayan, T.V. (2008, March 2). That secret disease. The Telegraph (Calcutta).

14.

Jeffery, R. , Ecks, S. , & Brhlikova, P. (2007). Global assemblages of pharmaceuticals: Rethinking TRIPS and GMP. Biblio, 30(3), 45-52.

15.

Kirmayer, L. , & Minas, H. (2000). The future of cultural psychiatry: An international perspective. Canadian Journal of Psychiatry, 45(5), 438-446.

16.

Mao Tse-tung. (1979). In memory of Norman Bethune, Dec. 21, 1939. In Selected works of Mao Tse-tung, Vol. 2. Peking: Foreign Languages Press. Retrieved, July 31, 2007, from http://www.marxists.org/reference/archive/mao/selectedworks/volume-2/mswv2_25.htm . (Original work published 1939)

17.

Pharmabiz. (2006, December 29). OPPI to adopt marketing code for medicine. Retrieved, July 31, 2007, from http://www.pharmabiz.com/article/detnews.asp?articleid=36892&sectionid=43 .

18.

Rose, N. (2006). Disorders without borders? The expanding scope of psychiatric practice. BioSocieties, 1, 465-484.

19.

Tripathi, S.K. , Dey, D. , & Hazra, A. (2005). Medicine prices and affordability in the state of West Bengal, India: Report of a survey supported by World Health Organization and Health Action International. Retrieved, July 31, 2007, from http://www.haiweb.org/medicineprices/surveys/200412IW/survey_report.pdf .

20.

World Health Organization. (WHO). (2001). Mental health: New understanding, new hope: The world health report 2001. Geneva: World Health Organization.